161 related articles for article (PubMed ID: 14628293)
1. Stereospecificity of flobufen metabolism in guinea pigs in vitro and in vivo: phase I of biotransformation.
Kral R; Skalova L; Szotakova B; Babu YN; Wsol V
Chirality; 2004 Jan; 16(1):1-9. PubMed ID: 14628293
[TBL] [Abstract][Full Text] [Related]
2. Stereospecificity and stereoselectivity of flobufen metabolic profile in male rats in vitro and in vivo: phase I of biotransformation.
Wsól V; Král R; Skálová L; Szotáková B; Trejtnar F; Flieger M
Chirality; 2001; 13(10):754-9. PubMed ID: 11746815
[TBL] [Abstract][Full Text] [Related]
3. The stereospecificity of flobufen metabolism in isolated guinea pig hepatocytes.
Kral R; Skalova L; Szotakova B; Velik J; Schroterova L; Babu YN; Wsol V
BMC Pharmacol; 2003 Jun; 3():5. PubMed ID: 12791169
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of flobufen enantiomers in ruminant hepatocytes and subcellular fractions.
Skálová L; Szotáková B; Lamka J; Král R; Vanková I; Baliharová V; Wsól V
Chirality; 2001; 13(10):760-4. PubMed ID: 11746816
[TBL] [Abstract][Full Text] [Related]
5. Chiral aspects of metabolism of antiinflammatory drug flobufen in human hepatocytes.
Skálová L; Král R; Szotáková B; Babú YN; Pichard-Garcia L; Wsól V
Chirality; 2003 May; 15(5):433-40. PubMed ID: 12692889
[TBL] [Abstract][Full Text] [Related]
6. Reduction of flobufen in pig hepatocytes: effect of pig breed (domestic, wild) and castration.
Skálová L; Wsól V; Baliharová V; Král R; Szotáková B; Velík J; Lamka J
Chirality; 2003 Mar; 15(3):213-9. PubMed ID: 12582986
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective pharmacokinetics and metabolism of flobufen in guinea pigs.
Trejtnar F; Král R; Pávek P; Wsól V
Chirality; 2003 Oct; 15(8):724-9. PubMed ID: 12923810
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective pharmacokinetics of flobufen in rats.
Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
[TBL] [Abstract][Full Text] [Related]
9. A comparison between stereospecificity of oracin reduction and stereoselectivity of oxidation of 11-dihydrooracin enantiomers in vitro in rat and guinea pig.
Skálová L; Wsól V; Szotáková B; Kvasnicková E
Chirality; 1999; 11(5-6):510-5. PubMed ID: 10368925
[TBL] [Abstract][Full Text] [Related]
10. The main metabolic pathway of oracin, a new potential cytostatic drug, in human liver microsomes and cytosol: stereoselectivity of reoxidation of the principal metabolite 11-dihydrooracin to oracin.
Wsól V; Szotáková B; Skálová L; Cepková H; Kvasnicková E
Enantiomer; 2000; 5(3-4):263-70. PubMed ID: 11126866
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in stereospecificity of oracin reductases in rat in vitro and in vivo.
Wsól V; Skálová L; Szotáková B; Trejtnar F; Kvasnicková E
Chirality; 1999; 11(5-6):505-9. PubMed ID: 10368924
[TBL] [Abstract][Full Text] [Related]
12. Warfarin: stereochemical aspects of its metabolism in vivo in the rat.
Pohl LR; Bales R; Trager WF
Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):233-56. PubMed ID: 981784
[TBL] [Abstract][Full Text] [Related]
13. Stereospecific reduction of the original anticancer drug oracin in rat extrahepatic tissues.
Szotáková B; Skálová L; Jílek P; Buchta V; Wsól V
J Pharm Pharmacol; 2003 Jul; 55(7):1003-11. PubMed ID: 12906758
[TBL] [Abstract][Full Text] [Related]
14. Metabolic pathways of flobufen-a new antirheumatic and antiarthritic drug. Interspecies comparison.
Kvasnicková E; Szotáková B; Wsól V; Trejtnar F; Skálová L; Hais IM; Kuchar M; Poppová M
Exp Toxicol Pathol; 1999 Jul; 51(4-5):352-6. PubMed ID: 10445396
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatographic-electrospray mass spectrometric determination (LC-ESI-MS) of phase II metabolites of flobufen in rat liver microsomes-Chiral discrimination.
Babú YN; Nemec M; Solich P; Wsól V
Talanta; 2008 Apr; 75(2):494-502. PubMed ID: 18371912
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective reversible ketone formation from 10-hydroxylated nortriptyline metabolites in human liver.
Breyer-Pfaff U; Nill K
Xenobiotica; 1995 Dec; 25(12):1311-25. PubMed ID: 8719907
[TBL] [Abstract][Full Text] [Related]
17. Stereospecificity of enzymatic hydrogen transfer to loxoprofen, a non-steroidal antiinflammatory agent, in the rat.
Naganuma H; Kawahara Y
Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):173-85. PubMed ID: 2396045
[TBL] [Abstract][Full Text] [Related]
18. Selective metabolism of E-3,4-bis(4-ethylphenyl)hex-3-ene in rat liver microsomes.
Fabian EJ; Metzler M
Arch Toxicol; 2006 Jan; 80(1):17-26. PubMed ID: 16187102
[TBL] [Abstract][Full Text] [Related]
19. Enantiomeric aspects of the metabolism of mianserin in rats.
Heinig R; Delbressine LP; Kaspersen FM; Blaschke G
Arzneimittelforschung; 1993 Jul; 43(7):709-15. PubMed ID: 8369000
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.
Zhao Z; Koeplinger KA; Bundy GL; Banitt LS; Padbury GE; Hauer MJ; Sanders PE
Drug Metab Dispos; 1996 Feb; 24(2):187-98. PubMed ID: 8742230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
